Cargando…
Exosome therapeutics for lung regenerative medicine
Exosomes are 30 to 100 nm extracellular vesicles that are secreted by many cell types. Initially viewed as cellular garbage with no biological functions, exosomes are now recognized for their therapeutic potential and used in regenerative medicine. Cell-derived exosomes are released into almost all...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480570/ https://www.ncbi.nlm.nih.gov/pubmed/32944172 http://dx.doi.org/10.1080/20013078.2020.1785161 |
_version_ | 1783580437912748032 |
---|---|
author | Popowski, Kristen Lutz, Halle Hu, Shiqi George, Arianna Dinh, Phuong-Uyen Cheng, Ke |
author_facet | Popowski, Kristen Lutz, Halle Hu, Shiqi George, Arianna Dinh, Phuong-Uyen Cheng, Ke |
author_sort | Popowski, Kristen |
collection | PubMed |
description | Exosomes are 30 to 100 nm extracellular vesicles that are secreted by many cell types. Initially viewed as cellular garbage with no biological functions, exosomes are now recognized for their therapeutic potential and used in regenerative medicine. Cell-derived exosomes are released into almost all biological fluids, making them abundant and accessible vesicles for a variety of diseases. These naturally occurring nanoparticles have a wide range of applications including drug delivery and regenerative medicine. Exosomes sourced from a specific tissue have been proven to provide greater therapeutic effects to their native tissue, expanding exosome sources beyond traditional cell lines such as mesenchymal stem cells. However, standardizing production and passing regulations remain obstacles, due to variations in methods and quantification techniques across studies. Additionally, obtaining pure exosomes at sufficient quantities remains difficult due to the heterogeneity of exosomes. In this review, we will underline the uses of exosomes as a therapy and their roles in lung regenerative medicine, as well as current challenges in exosome therapies. |
format | Online Article Text |
id | pubmed-7480570 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-74805702020-09-16 Exosome therapeutics for lung regenerative medicine Popowski, Kristen Lutz, Halle Hu, Shiqi George, Arianna Dinh, Phuong-Uyen Cheng, Ke J Extracell Vesicles Review Article Exosomes are 30 to 100 nm extracellular vesicles that are secreted by many cell types. Initially viewed as cellular garbage with no biological functions, exosomes are now recognized for their therapeutic potential and used in regenerative medicine. Cell-derived exosomes are released into almost all biological fluids, making them abundant and accessible vesicles for a variety of diseases. These naturally occurring nanoparticles have a wide range of applications including drug delivery and regenerative medicine. Exosomes sourced from a specific tissue have been proven to provide greater therapeutic effects to their native tissue, expanding exosome sources beyond traditional cell lines such as mesenchymal stem cells. However, standardizing production and passing regulations remain obstacles, due to variations in methods and quantification techniques across studies. Additionally, obtaining pure exosomes at sufficient quantities remains difficult due to the heterogeneity of exosomes. In this review, we will underline the uses of exosomes as a therapy and their roles in lung regenerative medicine, as well as current challenges in exosome therapies. Taylor & Francis 2020-06-29 /pmc/articles/PMC7480570/ /pubmed/32944172 http://dx.doi.org/10.1080/20013078.2020.1785161 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of The International Society for Extracellular Vesicles. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Popowski, Kristen Lutz, Halle Hu, Shiqi George, Arianna Dinh, Phuong-Uyen Cheng, Ke Exosome therapeutics for lung regenerative medicine |
title | Exosome therapeutics for lung regenerative medicine |
title_full | Exosome therapeutics for lung regenerative medicine |
title_fullStr | Exosome therapeutics for lung regenerative medicine |
title_full_unstemmed | Exosome therapeutics for lung regenerative medicine |
title_short | Exosome therapeutics for lung regenerative medicine |
title_sort | exosome therapeutics for lung regenerative medicine |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480570/ https://www.ncbi.nlm.nih.gov/pubmed/32944172 http://dx.doi.org/10.1080/20013078.2020.1785161 |
work_keys_str_mv | AT popowskikristen exosometherapeuticsforlungregenerativemedicine AT lutzhalle exosometherapeuticsforlungregenerativemedicine AT hushiqi exosometherapeuticsforlungregenerativemedicine AT georgearianna exosometherapeuticsforlungregenerativemedicine AT dinhphuonguyen exosometherapeuticsforlungregenerativemedicine AT chengke exosometherapeuticsforlungregenerativemedicine |